Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jan 31 2025

Full Issue

Longer Looks: Interesting Reads You Might Have Missed

Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on drug trials, cancer, Alzheimer's, polar bears, and more.

The New York Times: Would You Get Sick In The Name Of Science?

One cold morning in Baltimore last October, a 26-year-old named Alexander Laurenson strode into a small white room to have his arm preyed upon by mosquitoes. As requested, he had not showered the night before to make his skin more attractive to the pests, which are drawn to body odor. The mosquitoes, for their part, had been infected with malaria, a disease that kills over 600,000 people every year. Mr. Laurenson was part of a study to test the effectiveness of a new monoclonal antibody designed to prevent malaria transmission. (Crane, 1/28)

The New York Times: When ‘Cancer’ Gets In The Way Of Treatment 

A diagnosis is more than words on a page. It’s everything that comes with it: the doctor’s tone of voice, a gentle touch of the hand, the pauses left so the patient can digest the news. All of these details subtly impart how you should think about the label that you’ve just been given. But one diagnostic word in particular threatens to derail any rational discussion of its meaning: cancer. (Gross, 1/28)

The New York Times: Could Ozempic Protect Against Alzheimer’s? 

Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s disease in mice. Now, as the next generation of these medications has soared in popularity, and scientists discover they may have wide-ranging health benefits, research is revving up to investigate whether the drugs that upended diabetes and obesity care could also revolutionize Alzheimer’s treatment. Emerging evidence seems encouraging — but questions and caveats abound. (Smith and Blum, 1/31)

The Guardian: ‘We’re Witnesses To The Horror Of The World’: The One-Of-A-Kind Italian Clinic Treating Refugees For Trauma 

Tucked away in a tangle of streets around Rome’s Termini station is a clinic that sharply contrasts with the hardline, anti-migrant stance of Italian politicians. The Samifo Centre is described by the people behind it as Europe’s – and perhaps the world’s – only publicly funded service aimed at treating post-traumatic stress disorder and trauma among asylum seekers and refugees. (Kassam, 1/27)

The Washington Post: Polar Bear Fur Could Hold The Secret To Replacing ‘Forever Chemicals’

White fur, blubbery skin, sharp claws. Polar bears seem perfectly adapted to their frigid habitat up north. Now, researchers have discovered the bears have another unexpected Arctic adaptation: greasy fur. It’s a trait that, surprisingly, might help us find alternatives to “forever chemicals,” a class of widely used compounds that are linked to a range of health problems in people. ... By re-creating the bears’ ability to resist icing, researchers hope to develop healthier alternatives to these toxic chemicals. (Grandoni, 1/29)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF